Add BrightSurf on Google Email

University of California - San Diego


Evolutionary gene loss may help explain why only humans are prone to heart attacks

Researchers suggest a genetic mutation two to three million years ago led to a heightened risk of cardiovascular disease in all humans, while also setting up a further risk for red meat-eating humans. Human-like mice modified to lack the CMAH gene showed a significant increase in atherogenesis compared to control mice.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJul 22, 2019

Culture shapes how we learn to reason?

A new study published in the Proceedings of the National Academy of Sciences found that cultural environment influences early diversity in abstract thought. Chinese children demonstrated superior relational reasoning skills compared to US children, with significant differences emerging around age 3.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJun 24, 2019

Engineers use graph networks to accurately predict properties of molecules and crystals

Nanoengineers developed new graph network-based models that accurately predict material properties, outperforming existing AI technology in complex tasks. The MEGNet models can learn relationships between elements and overcome data limitations in materials science, enabling rapid discovery of transformative materials.

SourceUniversity of California - San Diego·JournalChemistry of Materials·DateJun 10, 2019

It's in the weeds: Herbicide linked to human liver disease

A recent study published in Clinical Gastroenterology and Hepatology found a significant association between glyphosate exposure and nonalcoholic fatty liver disease (NAFLD) in human subjects. The study, led by Paul J. Mills, PhD, examined urine samples from patients with NAFLD and healthy individuals, revealing higher levels of glypho...

SourceUniversity of California - San Diego·JournalClinical Gastroenterology and Hepatology·DateMay 14, 2019

Men taking medications for enlarged prostate face delays in prostate cancer diagnosis

Research reveals men treated for benign prostatic hyperplasia (BPH) with 5-α-reductase inhibitors experienced a two-year delay in prostate cancer diagnosis and were twice as likely to have advanced disease. PSA suppression from these medications led to delays in diagnosis, potentially resulting in worsened clinical outcomes.

SourceUniversity of California - San Diego·JournalJAMA Internal Medicine·DateMay 6, 2019